Offering of 4.000% Senior Notes due 2026
On June 6, 2018, The Chemours
Company (the “Company”) closed the public underwritten offering (the “Offering”) of
€450,000,000 aggregate principal amount of the Company’s 4.000% Senior Notes due 2026 (the “Notes”),
pursuant to the Underwriting Agreement (the “Underwriting Agreement”), dated as of May 22, 2018, by and among the
Company, the guarantors named therein (the “Guarantors”) and the several underwriters named therein. The Notes
were issued pursuant to the Indenture, dated as of May 23, 2017 (the “2017 Base Indenture”), between the Company
and U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by the Second Supplemental
Indenture setting forth the terms of the Notes, dated as of June 6, 2018, among the Company, the Guarantors, the Trustee,
Elavon Financial Services DAC, UK Branch, as paying agent (the “Paying Agent”), and Elavon Financial Services
DAC, as the registrar and transfer agent (the “Registrar and Transfer Agent”) (the “Second
Supplemental Indenture” and together with the 2017 Base Indenture, the “Indenture”). The Notes were offered
and sold pursuant to a registration statement on Form S-3 (File No.
333-217642
),
including the related prospectus, as supplemented by a prospectus supplement filed with the Securities and
Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended. The net proceeds from the Offering,
together with cash on hand, will be used to repurchase or redeem, as applicable, €294,679,000 of the Company’s
outstanding 6.125% Senior Notes due 2023 and $250,000,000 of the Company’s outstanding 6.625% Senior Notes due 2023,
and to pay any related fees, expenses and commissions related to the foregoing and to the Offering.
The Company will pay interest on the Notes,
semi-annually in arrears on May 15 and November 15 of each year, beginning on November 15, 2018. The Notes will mature on May 15,
2026.
The Company may redeem the Notes, in
whole or in part, from time to time at its option, prior to May 15, 2021, at redemption prices equal to 100% of the aggregate
principal amount of the Notes to be redeemed, plus the applicable “make-whole” premium and accrued and unpaid
interest, if any, to, but excluding, the redemption date. Also, at any time prior to May 15, 2021, the Company may redeem up
to 35% of the aggregate principal amount of the Notes with the net cash proceeds from certain equity offerings at a price
equal to 104.000% of the principal amount of such Notes, plus accrued and unpaid interest, if any, to, but excluding, the
redemption date. On or after May 15, 2021, the Company may redeem the Notes, in whole or in part, from time to time at its
option, at the redemption prices set forth in the Indenture, plus accrued and unpaid interest, if any, to, but excluding, the
redemption date. In addition, the Company may redeem the Notes, at its option, in whole but not in part, in the event of
certain developments affecting United States taxation. In the event of the occurrence of both (1) a Change of Control (as
defined in the Second Supplemental Indenture) and (2) a Rating Event (as defined in the Second Supplemental
Indenture) within a specified period, unless the Company has previously exercised its optional redemption right with respect
to the Notes in whole, the Company will be required to offer to repurchase the Notes from the holders at a price in cash
equal to 101% of the then outstanding principal amount of the Notes, plus accrued and unpaid interest, if any, to, but
excluding, the date of repurchase.
The Indenture includes certain covenants,
including limitations on the Company’s ability to create certain liens on its assets or consolidate, merge or sell all or
substantially all of its assets, subject to a number of important exceptions as specified in the Indenture. The Notes are unsecured
and unsubordinated obligations of the Company and rank equally with all of the Company’s existing and future unsecured and
unsubordinated indebtedness outstanding from time to time. The Indenture contains customary event of default provisions.
2023 Notes Amendments
On June 6, 2018, the Company, the Guarantors,
the Trustee, the Paying Agent and the Registrar and Transfer Agent entered into the Fourth Supplemental Indenture (the “Fourth
Supplemental Indenture”) to the base indenture, dated as of May 12, 2015 (the “2015 Base Indenture”), among the
Company, the guarantors party thereto, the Trustee, the Paying Agent and the Registrar. The Fourth Supplemental Indenture effects
certain amendments (the “2023 Notes Amendments”) to the 2015 Base Indenture, as supplemented by the Third Supplemental
Indenture (the “Third Supplemental Indenture”), dated as of May 12, 2015, among the Company, the Guarantors, the Trustee,
the Paying Agent and the Registrar and Transfer Agent, setting forth the terms of the Company’s 6.125% Senior Notes due 2023
(the “2023 Notes”). Holders representing a majority of the aggregate principal amount of the 2023 Notes outstanding
(excluding any 2023 Notes owned by the Company or any Guarantor or by any person directly or indirectly controlling or controlled
by or under direct or indirect common control with the Company or any Guarantor) consented to the 2023 Notes Amendments.
The 2023 Notes Amendments amend the 2015
Base Indenture, as supplemented by the Third Supplemental Indenture, to shorten the minimum notice period: (i) for any optional
redemption of the 2023 Notes by the Company on or after May 15, 2018, from at least 30 days but not more than 60 days to at least
two business days but not more than 60 days; and (ii) for any optional redemption of the 2023 Notes by the Company at any time,
following a tender offer for all of the outstanding 2023 Notes at a price of at least 100% of the principal amount of the 2023
Notes tendered and where at least 90% in aggregate principal amount of the outstanding 2023 Notes have tendered, from at least
30 days but not more than 60 days to at least one business day but not more than 60 days.
The foregoing descriptions of the Underwriting
Agreement, the Second Supplemental Indenture, the Fourth Supplemental Indenture and the Notes do not purport to be complete and
are qualified in their entirety by reference to the full text of these documents, which are filed as Exhibits 1.1, 4.1, 4.2 and
4.3 respectively, to this Current Report on Form 8-K and are incorporated herein by reference.
On June 4, 2018, the Company issued a press
release announcing the early tender date of the previously announced tender offer and consent solicitation and receipt of the requisite
consents to approve the 2023 Notes Amendments. A copy of the press release is attached as Exhibit 99.1 to this Current Report on
Form 8-K and is incorporated herein by reference.